## Core Concept
Neonatal sepsis is a serious infection that occurs in newborns, typically within the first 28 days of life. Acute phase reactants are proteins whose plasma concentrations increase or decrease in response to inflammation. In the context of neonatal sepsis, identifying reliable acute phase reactants is crucial for early diagnosis and intervention.

## Why the Correct Answer is Right
The correct answer, **C. C-reactive protein (CRP)**, is a well-established acute phase reactant. CRP is synthesized in the liver in response to inflammation and infection, making it a sensitive marker for detecting sepsis. Its levels rise significantly within hours of the onset of infection, allowing for early detection and treatment. CRP is widely used in clinical practice for monitoring the response to treatment and for guiding the decision to discontinue antibiotics.

## Why Each Wrong Option is Incorrect
* **Option A:** Procalcitonin is indeed a biomarker used in the diagnosis of sepsis, including neonatal sepsis. However, it is not the most universally recognized acute phase reactant compared to CRP.
* **Option B:** Erythrocyte sedimentation rate (ESR) is another marker of inflammation but is less specific and less commonly used in the acute setting of neonatal sepsis compared to CRP.
* **Option D:** Lactoferrin is a protein found in various secretory fluids and has antimicrobial properties. While it has been studied as a potential biomarker for neonatal sepsis, it is not as widely recognized or used as CRP.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that **C-reactive protein (CRP) levels can help differentiate between viral and bacterial infections**, with higher levels typically associated with bacterial infections. This can guide antibiotic therapy in neonates. However, it's essential to consider CRP in the context of clinical presentation and other diagnostic findings.

## Correct Answer: C. C-reactive protein (CRP).